The growing cardiology subsector is one of the most sought-after and competitive specialties for healthcare investors.

Stemming from an aging population and growing obesity demographic trends, demand for cardiovascular services is projected to increase significantly. The American Heart Association reports that between 2017 and 2020, 127.9 million U.S. adults had some form of cardiovascular disease.…

On this episode of Across the Table, McGuireWoods partner Alyssa Campbell is joined by Colin McDermott and Savanna Ganyard of VMG Health for a discussion of the publicly traded healthcare operator’s Q1 earnings reports and expectations for the rest of 2023. They also touch on whether today’s investment climate reflects a return to typical healthcare…

In this episode of The Capital Corner, Pete Tedesco of Health Enterprise Partners joins host Geoff Cockrell to discuss post-pandemic demands within the healthcare industry and the growing interest in investment of niche healthcare sectors. Pete explains that it’s all about understanding the current industry climate — and it’s important to stay ahead of the

With increased demand for cosmetic procedures and wellness treatments, the med spa industry is booming and investor appetite in the space is increasing. Still, the industry presents some unique legal challenges that can impact transaction structuring.

Read on for six key points investors should know about the med spa landscape, particularly when structuring transactions and…

General Atlantic has led a growth investment into Gravie, according to a news release.

Gravie, based in Minneapolis, is an employer health benefits company. Founded in 2013, the company primarily works with small and midsize employers.

General Atlantic, based in New York, is a global growth equity firm that prefers to make more…

Arcline Investment Management has announced it has closed its third fund, Arcline Capital Partners III, with $4.5 billion. 

Arcline, based in Nashville, is a growth-oriented private equity firm.

Founded in 2019, the firm seeks to invest in a wide range of industries, including health, life sciences and medical technology.

Audax Private Equity has announced it has completed a growth investment in Pyramid Laboratories.

Pyramid, based in Costa Mesa, Calif., is a drug product contract development and manufacturing organization. Founded in 1988, the company provides formulation development, analytical and stability testing, and aseptic fill-finish manufacturing services focused on large molecule therapeutics.

Audax, with…